Promoting the integrated community case management of pneumonia in children under 5 years in Nigeria through the proprietary and patent medicine vendors: a cost-effectiveness analysis.

ABSTRACT:

Background

While evidence-based recommendations for the management pneumonia in under-5-year-olds at the community level with amoxicillin dispersible tablets (DT) were made by the World Health Organisation, initiatives to promote the integrated community case management (iCCM) of pneumonia through the proprietary and patent medicine vendors (PPMVs) have been poorly utilized in Nigeria, possibly due to low financial support and perceived benefit. This study provides costs, benefits and cost-effectiveness estimates and implications of promoting the iCCM through the PPMVs' education and support. The outcome of this study will help inform healthcare decisions in Nigeria.

Methods

This study was a cost-effectiveness analysis using a simulation-based Markov model. Two approaches we

SUBMITTER: Okafor CE 

PROVIDER: S-EPMC7905852 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature